New-onset diabetes and antihypertensive drugs

Giuseppe Mancia, Guido Grassi, Alberto Zanchetti

Research output: Contribution to journalArticle

243 Citations (Scopus)

Abstract

Observational studies have provided evidence that a consistent fraction (approximately 15-20%) of hypertensive patients displays a glucose intolerance state that may be aggravated by antihypertensive drug regimens based on thiazide diuretics or beta-blockers. This review examines the relative and absolute diabetogenic effects of antihypertensive drugs, by comparing the impact of 'new' (calcium antagonists, angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists) versus 'old' (diuretics and beta-blockers) drugs on new-onset diabetes in recent clinical trials. Evidence is provided that compared with diuretics and beta-blockers, new-onset diabetes is less common with 'new' drugs, and that conventional antihypertensive compounds, particularly when combined together, may amplify the natural time-dependent tendency towards the development of this metabolic disease. This paper provides new insights into the potential mechanisms responsible for the phenomenon and the clinical significance of antihypertensive drug-induced diabetes.

Original languageEnglish
Pages (from-to)3-10
Number of pages8
JournalJournal of Hypertension
Volume24
Issue number1
Publication statusPublished - Jan 2006

Fingerprint

Antihypertensive Agents
Diuretics
Sodium Chloride Symporter Inhibitors
Glucose Intolerance
Angiotensin Receptor Antagonists
Metabolic Diseases
Angiotensin-Converting Enzyme Inhibitors
Observational Studies
Clinical Trials
Calcium
Pharmaceutical Preparations

Keywords

  • Angiotensin inhibitors
  • Angiotensin-converting enzyme inhibitors
  • Beta-blockers
  • Calcium antagonists
  • Clinical trials
  • Diabetes
  • Diuretics

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology

Cite this

New-onset diabetes and antihypertensive drugs. / Mancia, Giuseppe; Grassi, Guido; Zanchetti, Alberto.

In: Journal of Hypertension, Vol. 24, No. 1, 01.2006, p. 3-10.

Research output: Contribution to journalArticle

Mancia, G, Grassi, G & Zanchetti, A 2006, 'New-onset diabetes and antihypertensive drugs', Journal of Hypertension, vol. 24, no. 1, pp. 3-10.
Mancia, Giuseppe ; Grassi, Guido ; Zanchetti, Alberto. / New-onset diabetes and antihypertensive drugs. In: Journal of Hypertension. 2006 ; Vol. 24, No. 1. pp. 3-10.
@article{338dfe11c4f441f78929d41f5ec1034e,
title = "New-onset diabetes and antihypertensive drugs",
abstract = "Observational studies have provided evidence that a consistent fraction (approximately 15-20{\%}) of hypertensive patients displays a glucose intolerance state that may be aggravated by antihypertensive drug regimens based on thiazide diuretics or beta-blockers. This review examines the relative and absolute diabetogenic effects of antihypertensive drugs, by comparing the impact of 'new' (calcium antagonists, angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists) versus 'old' (diuretics and beta-blockers) drugs on new-onset diabetes in recent clinical trials. Evidence is provided that compared with diuretics and beta-blockers, new-onset diabetes is less common with 'new' drugs, and that conventional antihypertensive compounds, particularly when combined together, may amplify the natural time-dependent tendency towards the development of this metabolic disease. This paper provides new insights into the potential mechanisms responsible for the phenomenon and the clinical significance of antihypertensive drug-induced diabetes.",
keywords = "Angiotensin inhibitors, Angiotensin-converting enzyme inhibitors, Beta-blockers, Calcium antagonists, Clinical trials, Diabetes, Diuretics",
author = "Giuseppe Mancia and Guido Grassi and Alberto Zanchetti",
year = "2006",
month = "1",
language = "English",
volume = "24",
pages = "3--10",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - New-onset diabetes and antihypertensive drugs

AU - Mancia, Giuseppe

AU - Grassi, Guido

AU - Zanchetti, Alberto

PY - 2006/1

Y1 - 2006/1

N2 - Observational studies have provided evidence that a consistent fraction (approximately 15-20%) of hypertensive patients displays a glucose intolerance state that may be aggravated by antihypertensive drug regimens based on thiazide diuretics or beta-blockers. This review examines the relative and absolute diabetogenic effects of antihypertensive drugs, by comparing the impact of 'new' (calcium antagonists, angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists) versus 'old' (diuretics and beta-blockers) drugs on new-onset diabetes in recent clinical trials. Evidence is provided that compared with diuretics and beta-blockers, new-onset diabetes is less common with 'new' drugs, and that conventional antihypertensive compounds, particularly when combined together, may amplify the natural time-dependent tendency towards the development of this metabolic disease. This paper provides new insights into the potential mechanisms responsible for the phenomenon and the clinical significance of antihypertensive drug-induced diabetes.

AB - Observational studies have provided evidence that a consistent fraction (approximately 15-20%) of hypertensive patients displays a glucose intolerance state that may be aggravated by antihypertensive drug regimens based on thiazide diuretics or beta-blockers. This review examines the relative and absolute diabetogenic effects of antihypertensive drugs, by comparing the impact of 'new' (calcium antagonists, angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists) versus 'old' (diuretics and beta-blockers) drugs on new-onset diabetes in recent clinical trials. Evidence is provided that compared with diuretics and beta-blockers, new-onset diabetes is less common with 'new' drugs, and that conventional antihypertensive compounds, particularly when combined together, may amplify the natural time-dependent tendency towards the development of this metabolic disease. This paper provides new insights into the potential mechanisms responsible for the phenomenon and the clinical significance of antihypertensive drug-induced diabetes.

KW - Angiotensin inhibitors

KW - Angiotensin-converting enzyme inhibitors

KW - Beta-blockers

KW - Calcium antagonists

KW - Clinical trials

KW - Diabetes

KW - Diuretics

UR - http://www.scopus.com/inward/record.url?scp=29244436688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29244436688&partnerID=8YFLogxK

M3 - Article

C2 - 16331092

AN - SCOPUS:29244436688

VL - 24

SP - 3

EP - 10

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 1

ER -